Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Universal Health Services is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G2026-10-08SCHEDULE 13G
- 8-K2026-08-21Current report (material event)
- S-82026-08-18Employee stock plan
- 8-K2026-08-17Current report (material event)
- 8-K2026-08-13Current report (material event)
- 424B52026-08-13Prospectus (offering)
- FWP2026-08-12FWP
- 424B52026-08-10Prospectus (offering)
- POSASR2026-08-07POSASR
- 10-Q2026-08-07Quarterly report
- SCHEDULE 13G/A2026-08-06SCHEDULE 13G/A
- 8-K2026-07-28Current report (material event)
- 8-K2026-07-21Current report (material event)
- 8-K2026-05-22Current report (material event)
- 8-K2026-05-21Current report (material event)
- 10-Q2026-05-07Quarterly report
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- 8-K2026-04-28Current report (material event)
- 8-K2026-04-24Current report (material event)
- DEFA14A2026-04-09DEFA14A
- ARS2026-04-09Annual report to holders
- DEF 14A2026-04-09Proxy statement
- 8-K2026-03-30Current report (material event)
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 8-K2026-03-09Current report (material event)
- 8-K2026-02-26Current report (material event)
- 10-K2026-02-25Annual report
- 8-K2025-12-31Current report (material event)
- 10-Q2025-11-07Quarterly report
- 8-K2025-10-28Current report (material event)
- 8-K2025-09-29Current report (material event)
- 10-Q2025-08-08Quarterly report
- 8-K2025-07-29Current report (material event)
- 8-K2025-05-15Current report (material event)
- 10-Q2025-05-08Quarterly report
- 8-K2025-04-29Current report (material event)
- SCHEDULE 13G/A2025-04-17SCHEDULE 13G/A
- DEFA14A2025-04-03DEFA14A
- ARS2025-04-03Annual report to holders
- DEF 14A2025-04-03Proxy statement
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.